Li-Yuan Bai, M.D., Ph.D., is the director of Division of Hematology and Oncology, and the deputy director of Clinical Trial Center at China Medical University Hospital, Taichung, Taiwan. The interest fields of professor Bai include cancer of gastrointestinal tract, pancreas, biliary tract, gastrointestinal stromal tumor, and neuroendocrine tumor. He has participated many international clinical trials in relevant fields and is the leading principle investigator in three PI-initiated, multicenter clinical trials. Prof. Bai is also active in first-in-human and early phase clinical trials, with the engagement of 34 first-in-human or phase I trials between 2014 to 2022.

Dr. Shih-Sheng Chang is a senior intervention cardiologist specializing in complex coronary artery disease and acute coronary syndrome. He serves as the Director of Interventional Cardiology and actively contributes to Taiwan‘s cardiology field as a board member of the Taiwan Society of Cardiology and director at the Myocardial Infarction Society. From 2022 to 2024, Dr. Chang furthered his expertise in AI applications in cardiology at NIH and Mayo Clinic, focusing on computer vision techniques to support diagnostic cardiology. Now leading the AI Center at China Medical University Hospital, he collaborates with physicians to develop patient-centered smart healthcare solutions. Recently, Dr. Chang was invited to present at the HIMSS Asia-Pacific Conference, sharing insights from his team’s innovations in smart healthcare.

Diagnostic Nuclear Medicine Positron Emission Tomography Therapeutic Nuclear Medicine

Dr. Cheng specializes in the treatment of sleep disorders, occupational stress, smoking, alcohol and drug addiction, obsessive-compulsive disorder, panic disorder, and autonomic nervous system dysfunction. She holds certifications as a sleep specialist, addiction specialist, and occupational medicine physician. Having received psychoanalytic psychotherapy training, she offers treatment options for psychoneurotic disorders beyond pharmacotherapy. Her clinical service and scientific research have been outstanding. In 2007, she received the Best Physician Award from Taipei City Hospital, in 2015, she was awarded the Outstanding Graduate Award from National Taiwan University, and in 2018, she was honored with the Excellent Physician Award and Excellent Teaching Award from China Medical University Hospital. She was awarded research grants from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) in collaboration with the Finnish Academy in both 2018 and 2019, and in 2019, she received the Young Researcher Award from the Taiwan Society of Addiction Science.

Stroke, dyskinesia, peripheral neuropathy and general neurology

Internal medicine
Cardiovascular diseases

Translational Research on Chinese Herbal Medicine and Natural Medicinal Products - Functional Food and New Drug Development

Pharmacochemistry, Natural ingredient activity, Development of new drugs

Organic chemistry, New drug development, Pharmacochemistry

Organic Chemistry, asymmetric organic inducer, natural product chemical combination, glycochemistry and glycobiology, development of new drugs.